Skip to main content

MoneyWorks4Me

Lupin informs about press release

02 Mar 2021 Evaluate
Lupin has informed that it has enclosed press release titled ‘Lupin Launches Penicillamine Tablets USP’, under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1760.00
Dr. Reddys Labs. 1305.00
Cipla 1350.00
Lupin 1959.05
Zydus Lifesciences 1167.00
View more..